The role of HIPEC in ovarian cancer treatment by Matt Anderson ⁦csmottcenter⁩

CTGF and the Origen of ovarian cancer. Great presentation of Dr Gogoi ⁦csmottcenter⁩

Excited to work with this incredible collaboration of clinical, translational, and bioinformatics researchers dedicated to advancing research and treatment options in ovarian cancer! Gil Mor csmottcenter Tampa General Hospital USF Health Medicine

A Cancer Patient’s Last Wish: To Pay Off the Medical Debt of Others nytimes.com/2023/11/19/us/…

A superb video by Dr. Kevin Chan Kevin Chan, MD & City of Hope Surgery #Urology Team describing the technique for creation of Indiana Pouch Continent Cutaneous #UrinaryDiversion doi.org/10.1016/j.urol… Ali Zhumkhawala, MD Jonathan Yamzon Bertram Yuh Wesley Yip @claytonlaumd Genitourinary Cancer Research Team @CityofHope City of Hope

Major Medical Journal Reverses Itself On “Research Parasites” As NIH Beefs Up Data Sharing Rules forbes.com/sites/stevensa…

Enjoy all!! sciencedirect.com/science/articl…

No cervical cancer cases in fully HPV-vaccinated women in Scotland - BBC News bbc.com/news/articles/…

Such an amazing #MDT for #endometriosis USFObGynResidency Tampa General Hospital USF REI Fellowship all with different background and training coming together to provide the best care possible Diana Encalada Soto, MD, OBGYN, MIGS Lauri Hochberg Anthony Imudia, MD Papri Sarkar #SoMe4Endometriosis

Congrats Theresa Kuhn on her important study assessing the use of p53 mutation type and copy number signatures for risk stratification in high grade serous ovarian cancer. #sgomtg ⁦Nathalie Mckenzie, MD MSPH⁩ ⁦AdventHealth⁩ ⁦SGO⁩

Eternal debate around addition of #HIPEC in #OvarianCancer Positive results for interval debulking from NCDB database Great work by Adrian Kohut at SGO #SGOmtg #PowerofSharedPurpose

ascopubs.org/doi/10.1200/JC… We are getting closer to early detect ovarian cancer. The future is bright. OncoAlert The GOG Foundation Inc. Mount Sinai Miami OB/GYN Karen Lu

New updated review of the hallmarks on #cancer published in Cell this week. Embracing cancer complexity: Hallmarks of systemic disease ⁦⁦OncoAlert⁩ cell.com/cell/fulltext/…

Congratulations to our chief resident Colton Ladbury, MD and Scott Glaser on their manuscript using machine learning to examine disparities in brachytherapy receipt for cervical cancer. Check out the model here: …ogymachinelearning.pythonanywhere.com/brachy doi.org/10.1016/j.brac…

For those graduating from fellowship/residency this year; training is tough and difficult. As you get ready to take on your new role, consider this quote from Will Durant - “Those who have suffered much become very bitter or very gentle.” I urge you to consider the latter!

linkedin.com/posts/matthew-…

TP53: - Discovered 45 years ago, most cited gene all time - No therapies - 500 million people currently living will die of TP53 mutant cancers without new therapies Our Preprint: - A general strategy for TP53 missense mutant cancers (majority) with prototype small molecules

This is the beginning- engineered cell therapy in solid tumors is here! I’m honored to lead SURPASS 3 evaluating engineered T cells targeting MAGEA4 expressing ovarian cancer- I hope we will see an encouraging signal here too! As always, indebted to our patient volunteers who do

facebook.com/share/p/Wm4Xp6…

Wow. Why are we not doing this in dMMR/MSI endometrial?